The Amplexd Team
Alia Rahman | Co-Founder and CEO
Motivated to avoid subsequent surgical procedures after a 15-year journey with dysplasia, Alia Rahman is a patient-scientist, engineer, award-winning entrepreneur, featured keynote speaker, long-time product developer, women’s health advocate, executive leadership coach, non-profit board member, polyglot, and long-distance road cyclist. Alia is Amplexd’s acting CEO, on a mission to develop and commercialize non and minimally-invasive dysplasia treatments that prioritize patient experience, access, and effectiveness. Alia speaks English, French, Spanish and Urdu.
Dr. Reid von Borstel, PhD | Co-Founder
Veteran pharmacologist, physiologist, and head of drug discovery at an emerging biotech company, with an undergrad degree in chemistry and a PhD in neuroscience, both from MIT, Dr. Reid von Borstel has invented two FDA-approved drugs and three FDA-cleared medical devices, and is an inventor on more than 140 issued US patents. His specialty is creating simple, safe solutions to complex medical and technical challenges. Reid spearheads Amplexd’s product development efforts on the technical and regulatory fronts.
Valent Turkovic | Medical Device – Program Manager
Valent Turkovic is a seasoned innovator and entrepreneur, recognized by Google as one of the 'Top 100 Innovators from Central and Eastern Europe.' With over 15 years of experience in wireless mesh networks and telecommunications infrastructure, Valent holds a CCNA certificate and is an expert in OpenWrt embedded operating systems. He is the founder of MeshPoint.One, a startup aimed at providing smart solutions for crisis situations and smart cities. His humanitarian efforts during the Syrian refugee crisis earned him an award for the best humanitarian innovation from UNICEF. Valent is the founder of 3D Tvornica, a 3D printing and prototyping company that has collaborated with a diverse range of clients across the EU, including Rimac Automobili, Bugatti, DOK-ING, and several others. At Amplexd, Valent brings his extensive product development experience and humanitarian ethos to the team, contributing to the development of medical devices that aim to revolutionize the treatment of cervical dysplasia and early cervical cancer in women.